Association of glucose kinase and glucokinase regulatory protein gene polymorphisms with type 2 diabetes mellitus susceptibility in the Asian population: A meta-analysis
Keywords:
GCK, GCKR, gene polymorphism, glucose kinase, meta-analysis, type 2 diabetes mellitusAbstract
Background: Type 2 diabetes mellitus (T2DM) is a condition in which the body struggles to regulate blood sugar levels. The glucose kinase (GCK) and glucokinase regulatory protein (GCKR) genes play a crucial role in glucose metabolism. GCK produces an enzyme essential for glucose sensing and insulin production, whereas GCKR regulates this enzyme’s activity.
Objective: This meta-analysis aimed to investigate the GCK rs1799884 and GCKR rs780094 gene polymorphisms and their association with T2DM in an Asian population.
Methods: This study identified articles for two genetic variations (GCK rs1799884 and GCKR rs780094) and assessed their link with type 2 diabetes. We searched online databases, such as Scopus and PubMed, for studies comparing individuals with and without T2DM. Metagenyo was employed as a tool to analyze the data and determine whether these genetic variations increased the risk of developing T2DM.
Results: This study suggests that genetic variations in GCK are associated with a higher risk of developing T2DM, regardless of the gene polymorphism in the allelic, recessive, and dominant models. However, analysis of the GCKR rs780094 gene polymorphism and T2DM revealed that these were only associated in the recessive model.
Conclusion: This study reveals that the GCK rs1799884 and GCKR rs780094 polymorphisms are associated with a higher chance of developing T2DM in the Asian population.
Downloads
References
Galicia-Garcia U, Benito-Vicente A, Jebari S, LarreaSebal A, Siddiqi H, Uribe KB, Ostolaza H, Martín C. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 2020;21:6275.
https://doi.org/10.3390/ijms21176275
Sturgeon LP, Bragg-Underwood TM, Blankenship M. Practice matters: prevention and care of individuals with type 2 diabetes. IJFCN 2016;2:32.
Roglic G. WHO Global report on diabetes: a summary. IJNCD 2016;1:3-8.
https://doi.org/10.4103/2468-8827.184853
Ogurtsova K, Da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH; IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128: 40-50.
https://doi.org/10.1016/j.diabres.2017.03.024
Meo SA, Zia I, Bukhari IA, Arain SA. Type 2 diabetes mellitus in Pakistan: Current prevalence and future forecast. J Pak Med Assoc 2016;66:1637-42.
Aamir AH, Ul-Haq Z, Mahar SA, Qureshi FM, Ahmad I, Jawa A, Sheikh A, Raza A, Fazid S, Jadoon Z, Ishtiaq O. Diabetes Prevalence Survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan. BMJ open 2019;9:e025300.
https://doi.org/10.1136/bmjopen-2018-025300
Harding JL, Weber MB, Shaw JE. The global burden of diabetes. Textbook of Diabetes 2024:28-40.
https://doi.org/10.1002/9781119697473.ch3
Tan WX, Sim X, Khoo CM, Teo AK. Prioritization of genes associated with type 2 diabetes mellitus for functional studies. Nat Rev Endocrinol 2023;19:477-86.
https://doi.org/10.1038/s41574-023-00836-1
Xiao S, Zeng X, Fan Y, Su Y, Ma Q, Zhu J, et al. Gene polymorphism association with type 2 diabetes and related gene-gene and gene-environment interactions in a Uyghur population. Med Sci Monit 2016;22:474-87.
Williams R, Periasamy M. Genetic and environmental factors contributing to visceral adiposity in Asian populations. Endocrinol Metab (Seoul) 2020;35:681.
https://doi.org/10.3803/EnM.2020.772
Wang L, Ma Q, Yao H, He LJ, Fang BB, Cai W, et al. Association of GCKR rs780094 polymorphism with circulating lipid levels in type 2 diabetes and hyperuricemia in Uygur Chinese. Int J Clin Exp Pathol2018;11:4684-94.
Gloyn AL. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat 2003;22:353-62.
https://doi.org/10.1002/humu.10277
Christesen HB, Jacobsen BB, Odili S, Buettger C, Cuesta-Munoz A, Hansen T, et al. The second activating glucokinase mutation (A456V) implications for glucose homeostasis and diabetes therapy. Diabetes 2002;51:1240-6.
https://doi.org/10.2337/diabetes.51.4.1240
Cuesta-Munoz AL, Huopio H, Otonkoski T, GomezZumaquero JM, Nanto-Salonen K, Rahier J, et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes 2004;53:2164-8.
https://doi.org/10.2337/diabetes.53.8.2164
Khamlich J, Douiyeh I, Saih A, Baggar A, Kettani A, Safi A. In silico analysis predicting the structural and functional effects of high-risk nsSNPs in the human GCK gene associated with gestational diabetes. Phys Chem Res 2023;11:653-73.
Awadallah EA, Hasan NS, Awad MA, Kamel SA, Yousef RN. Associations of GCKR, TCF7L2, SLC30A8, and IGFB polymorphisms with type 2 diabetes mellitus in Egyptian populations. Jordan J Biol Sci 2020;13.
Wang K, Shi M, Yang A, Fan B, Tam CHT, Lau E, et al. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong diabetes register (1995-2019). Diabetes Res Clin Pract 2022;193:110118.
https://doi.org/10.1016/j.diabres.2022.110118
McCarthy M, Menzel S. The genetics of type 2 diabetes. Br J Clin Pharmacol 2001;51:195-9.
https://doi.org/10.1046/j.1365-2125.2001.00346.x
Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol 2021;69:2932-8.
https://doi.org/10.4103/ijo.IJO_1627_21
Babu BV, Hazarika CR, Raina SK, Masoodi SR, Basappa YC, Thomas N, et al. Prevalence of type 2 diabetes among tribal population of India: a multi-centric crosssectional study. J Natl Med Assoc 2024;116:153-64.
https://doi.org/10.1016/j.jnma.2024.01.004
Paliwal A, Paliwal V, Jain S, Paliwal S, Sharma S. Current insight on the role of glucokinase and glucokinase regulatory protein in diabetes. Mini Rev Med Chem 2024;24:674-88.
https://doi.org/10.2174/1389557523666230823151927
Shen M, Jiang L, Liu H, Dai H, Jiang H, Qian Y, et al. Interaction between the GCKR rs1260326 variant and serum HDL cholesterol contributes to HOMA-β and ISI Matusda in the middle-aged T2D individuals. J Hum Genet 2023;68:835-42.
https://doi.org/10.1038/s10038-023-01191-9
Ansari N, Ramachandran V, Mohamad NA, Salim E, Ismail P, Hazmi M, et al. Association of GCK (rs1799884), GCKR (rs780094), and G6PC2 (rs560887) gene polymorphisms with type 2 diabetes among Malay ethnics. Glob Med Genet 2023;10:12-8.
https://doi.org/10.1055/s-0042-1760384
She L, Li W, Guo Y, Zhou J, Liu J, Zheng W, et al. Association of glucokinase gene and glucokinase regulatory protein gene polymorphisms with gestational diabetes mellitus: A case-control study. Gene 2022;824:146378.
https://doi.org/10.1016/j.gene.2022.146378
Mir MM, Mir R, Alghamdi MAA, Wani JI, Elfaki I, Sabah ZU, et al. Potential impact of GCK, MIR- 196A-2, and MIR-423 gene abnormalities on the development and progression of type 2 diabetes mellitus in Asir and Tabuk regions of Saudi Arabia. Mol Med Rep 2022;25:162.
https://doi.org/10.3892/mmr.2022.12675
Fatima W, Khan F, Ali A, Verma AK. Association of GCK gene promoter polymorphism and their role in its MRNA expression among type 2 diabetes mellitus patients. J Clin Diagnos Res 2020;14-8.
https://doi.org/10.7860/JCDR/2020/42876.14135
Liu YY, Wan Q. Relationship between GCKR gene rs780094 polymorphism and type 2 diabetes with albuminuria. World J Diabetes 2023;14:1803-12.
https://doi.org/10.4239/wjd.v14.i12.1803
Stephen SB, Devaraj DV, Sivasubramanian J, Antony BS, Subbaraj GK. Transcription factor 7- like 2 gene polymorphism and type 2 diabetes mellitus: A meta-analysis. Biomedical Biotechnol Res J (BBRJ) 2023;7:513-23.
https://doi.org/10.4103/bbrj.bbrj_267_23
Aravindhan S, Almasoody MF, Selman NA, Andreevna AN, Ravali S, Mohammadi P, et al. Vitamin D receptor gene polymorphisms and susceptibility to type 2 diabetes: Evidence from a meta-regression and meta-analysis based on 47 studies. J Diabetes Metab Disord 2021;20: 845-67.
https://doi.org/10.1007/s40200-020-00704-z
Ikhanjal MA, Elouarid MA, Zouine C, Errafii K, Ghazal H, Alidrissi N, et al. FTO gene variants (rs9939609, rs8050136 and rs17817449) and type 2 diabetes mellitus risk: A meta-analysis. Gene 2023;887:147791.

Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Chulalongkorn Medical Journal

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.